Home / Lorlatinib / United States
US ATC L01ED05 · updated 2 Nov 2026
Lorlatinib shortage in United States
Is there a Lorlatinib shortage in United States?
Yes. As of 2 Nov 2026, 1 Lorlatinib product is reported short in United States, the first since 15 Jun 2026. No return date has been given. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Lorbrena, Tablet, 25 mg; 120 tablets bottle with a child-resistant closure (NDC 0069-0227-03) discontinuation | Pfizer Inc. | 15 Jun 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).